A clinical-stage biopharmaceutical company focused on developing therapies for acute gastrointestinal complications and inflammatory conditions. Its lead drug candidates target postoperative digestive dysfunction and other GI disorders, areas with limited treatment options. Investors track the compa...
6 members of Congress have disclosed 11 trades in Pali Corp (PALI), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-01 | Bradley S. Schneider | sell | $15K – $50K |
| 2018-10-04 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K – $15K |
| 2017-07-24 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K – $15K |
| 2012-07-11 | Todd Rokita | buy | $1K – $15K |
| 2011-09-08 | JAMES B. RENACCI | sell | $3,471.88 |
| 2011-09-08 | JAMES B. RENACCI | sell | $3,711.89 |
| 2011-07-12 | Todd Rokita | buy | $1K – $15K |
| 2011-06-08 | CHRISTOPHER JOHN LEE | buy | $1K – $15K |
| 2009-07-07 | F. JAMES SENSENBRENNER | buy | $11,142.00 |
| 2008-10-01 | CHRISTOPHER JOHN LEE | buy | $500K – $1M |
| 2008-06-11 | CHRISTOPHER JOHN LEE | buy | $50K – $100K |